Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | Additional standard NIH due dates through January 7, 2027

Funding Amounts: Up to $500,000 in direct costs per year; maximum project period 5 years; modular or detailed budget allowed

Summary: Supports investigator-initiated, low risk clinical trials to advance interventions for communication disorders, within NIDCD’s mission, that do not require FDA oversight and are not intended to establish efficacy.

Key Information: Applications must not exceed $500,000 in direct costs/year and must not require FDA IND/IDE; only low risk trials are eligible.